Intraoperative liver ultrasound represents an essential component in the hepatobiliary surgery arsenal, having an essential role in describing liver lesions, their topography, and loco-regional extension. It also has an important role in establishing surgical strategy, in modulating the surgeon decisions, and thus in preventing postoperative complications. This chapter tries to make a synthetic review of principal indications for using ultrasound in liver surgical treatment, underlining the liver’s lesions characteristics and advantages brought by this method. Also, we wanted to underline the importance that ultrasound has for guiding the surgeon in interventional intraoperative techniques or in any anatomical liver resection. The role of enhanced contrast intraoperative ultrasound is put in front by the better diagnostic results obtained for both primary and metastatic tumors of the liver.
Part of the book: Liver Research and Clinical Management
Hepatocellular carcinoma (HCC) is the most frequent primary malignant tumor of the liver, being the sixth most common cancer in the world and the third cause of cancer mortality. Most of the patients with HCC have an established background of cirrhosis and chronic liver disease. Magnetic resonance imaging (MRI) is the best technique for evaluation of the liver nodules in patients with cirrhosis, especially when a HCC is suspected. HCC staging is mandatory to select the appropriate primary and adjuvant therapy and to evaluate the prognosis. Hepatic resection is the treatment of choice in non-cirrhotic patients who have been diagnosed with HCC. In this chapter we underline the main diagnostic methods used for HCC staging, together with the treatment possibilities, highlighting the importance of surgical management, conventional or minimally invasive.
Part of the book: Liver Research and Clinical Management
Bartter and Gitelman syndromes are rare genetic disorders in which there are specific defects in kidney function, characterized by metabolic alkalosis, hypokalemia, hyperreninemia, and hyperaldosteronism, with or without hypomagnesemia. Blood pressure is normal or low in these patients. Positive diagnosis is one of the exclusions, and the difference between the two syndromes is based on urine calcium levels. Medication has to be taken lifelong. Renal transplantation can correct the transport defect in Bartter and Gitelman syndromes. The symptoms and severity vary from one person to another and can range from mild to severe. Age of onset of overt symptoms can range from before birth to adulthood.
Part of the book: Fluid and Electrolyte Disorders